Richard van den Broek - 06 Jun 2024 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
06 Jun 2024
Net transactions value
$0
Form type
4
Filing time
24 Jun 2024, 19:38:10 UTC
Previous filing
06 Jun 2023
Next filing
09 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 06 Jun 2024 Common Stock 20,000 $14.55 Direct F1
transaction PLSE Stock Option (right to buy) Award $0 +11,649 $0.000000 11,649 06 Jun 2024 Common Stock 11,649 $14.55 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 6, 2024.
F2 The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2024.